Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 43Terminated 5Unknown 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 46Liver Neoplasms 9Neoplasm Metastasis 4Leukemia, Myeloid, Acute 4Pancreatic Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Sarcoma 2Recurrence 2Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Breast Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Relapsed Pediatric Solid Tumor 1Portal Vein Tumor Thrombus 1Neoplasms, Glandular and Epithelial 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Site 1Neoplasms by Histologic Type 1Mesothelioma 1Lung Neoplasms 1Liver Diseases 1Leukemia, Monocytic, Acute 1Kidney Neoplasms 1Hemangiosarcoma 1HCC 1Gastrointestinal Neoplasms 1

Interventions

Exercise 19Drug Therapy 18pembrolizumab 13Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Paclitaxel 9Dexamethasone 9Nivolumab 8Standard of Care 7Oxaliplatin 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Control Groups 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neoplasms × Sorafenib × Clear all
NCT02015728 2016-12-15

SEED

Seattle Children's Hospital

Phase NA Unknown
20 enrolled

Neoplasms, Recurrence

NCT01214343 2011-06-15

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

Ministry of Health, Labour and Welfare, Japan

Phase 3 Unknown
190 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡